| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.044 | 0.3 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.067 | 0.3 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |